According to a press release, the speakers will be:
- Steven Tave, Director of FDA’s Office of Dietary Supplement Programs, will discuss regulatory priorities on October 14;
- Zachary Karabell, Global Authority of Economics and Politics, will explain the competitive advantages of companies that make sustainability a core component of their strategy on October 15;
- Jim Donald, Chairman of Albertson’s, will draw on years of experience regarding how to operate in uncertain business environments and share the structure he is using to consult with CEOs globally during the pandemic, as well as best practices for leading a company at every level, on October 16.
Related: 43% of Supplement Users Changed Usage Patterns Due to COVID Industry Groups Have Mixed Reactions to Legislation to Regulate CBD CRN-I Reports Focus on Healthy Aging, Role of Microbiome in Health & More
Before Now, New, Next, CRN is presenting “Science in Session”—two half-days discussing challenges and opportunities for public health recommendations around dietary supplements, taking place October 13-14. It will include presentations from top research scientists on topics including:- Supplements in the age of personalized nutrition
- Establishing Dietary Reference Intakes for bioactives under the DRI framework
- The evolving science of nutrition and public policy